Sanofi, FR0000120578

Sanofi faces EU probe, shares steady after Friday’s Reuters report

27.06.2026 - 15:10:53 | ad-hoc-news.de

Sanofi faces an EU antitrust probe over its flu vaccine campaign, according to Reuters. The Sanofi shares in Paris also carry a clear analyst anchor through the U.S. ADR, SNY.

Sanofi, FR0000120578
Sanofi, FR0000120578

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-27, 13:10.

Sanofi (FR0000120578) faces a European Commission antitrust probe over its flu vaccine marketing campaign, Reuters reported on Friday. The company trades in Paris on Euronext and on the New York market through the SNY ADR, which gives the stock a clear U.S. anchor as well.

What Reuters reported

The Reuters report said EU regulators are looking into possible anticompetitive conduct tied to a flu vaccine communication campaign. MarketScreener’s Sanofi page also lists the same June 26 news flow, including the positive EMA opinion on a meningococcal vaccine indication extension and the antitrust probe.

That combination matters because it links one regulatory headline to another dated development in the same week. Sanofi’s broad vaccine franchise remains central to the debate around the shares in Paris.

Consensus and ADR view

Sanofi’s U.S. ADR, SNY, closed at 42.95 dollars on Friday, June 26, according to TradingKey. TradingKey also shows a market capitalization of 103.75 billion dollars and an overall analyst rating of Buy, with an average price target of 57.30 dollars.

That gives retail investors a second reference point beside Euronext Paris. For cross-border coverage, the ADR and the Paris listing often move together, even if the daily cash session can differ.

Go deeper

All news and analysis on the Sanofi shares

The Sanofi dossier combines regulatory headlines, analyst views and market data across Paris and the U.S. ADR.

What Sanofi sells

Sanofi’s vaccine and specialty-care portfolio includes Dupixent, one of the group’s most important drugs, alongside a broad immunology and vaccines franchise. The vaccine business is the part now in the regulatory frame, based on the Reuters report and the MarketScreener news flow.

Sanofi shares today

The Sanofi shares (FR0000120578) trade on 2026-06-26, 16:00 ET on the U.S. ADR line at 42.95 dollars.

Sanofi at a glance

  • Company: Sanofi S.A.
  • ISIN: FR0000120578
  • Ticker: SNY
  • Trading venue: NYSE ADR
  • Price (as of 2026-06-26, 16:00): 42.95 USD
  • Market cap: 103.75 billion USD
  • Sector / industry: Health Care - Pharmaceuticals

More on the Sanofi shares in social media

Disclaimer: This article is for information only and does not constitute investment advice.

en | FR0000120578 | SANOFI | boerse | 69640836 | bgmi